MRD in Philadelphia Chromosome-Positive ALL: Methodologies and Clinical Implications

Abstract excerpt

PURPOSE OF REVIEW: Measurable residual disease (MRD) is integral in the management of Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). This review discusses the current methods used to evaluate MRD as well as the interpretation, significance, and incorporation of MRD in current practice. RECENT FINDINGS: . The most used techniques to evaluate MRD are multiparametric flow cytometry (MFC),...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Acute Lymphoblastic Leukemia research
• Share to CAR-T cell therapy research
• Share to Chronic Myeloid Leukemia Treatments